Great Point Partners LLC Biogen Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$223.92 - $287.77 $10.6 Million - $13.7 Million
-47,500 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $4.24 Million - $5.54 Million
15,000 Added 46.15%
47,500 $13.4 Million
Q2 2021

Aug 16, 2021
SELL
$259.0 - $414.71 $11 Million - $17.6 Million
-42,500 Reduced 56.67%
32,500 $11.3 Million
Q1 2021

May 17, 2021
BUY
$242.95 - $284.63 $18.2 Million - $21.3 Million
75,000 New
75,000 $21 Million

Others Institutions Holding BIIB

# of Institutions
1,035
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email